Interstitial lung disease is not rare in immune-mediated necrotizing myopathy with anti-signal recognition particle antibodies

OBJECTIVES: The purpose was to clarify the characteristics of interstitial lung disease (ILD) in immune-mediated necrotizing myopathy (IMNM) patients with anti-signal recognition particle (SRP) antibodies. METHODS: Medical records of IMNM patients with anti-SRP antibodies were reviewed retrospective...

Descripción completa

Detalles Bibliográficos
Autores principales: Ge, Yongpeng, Yang, Hanbo, Xiao, Xinyue, Liang, Lin, Lu, Xin, Wang, Guochun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744320/
https://www.ncbi.nlm.nih.gov/pubmed/35000598
http://dx.doi.org/10.1186/s12890-021-01802-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8744320/
https://www.ncbi.nlm.nih.gov/pubmed/35000598
http://dx.doi.org/10.1186/s12890-021-01802-1

Ejemplares similares